Mitochondrial disease heterogeneity

A prognostic challenge

Maurizio Moggio, Irene Colombo, Lorenzo Peverelli, Luisa Villa, Rubjona Xhani, Silvia Testolin, Salvatore Di Mauro, Monica Sciacco

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Mitochondrial diseases are a heterogeneous group of progressive, genetically transmitted, multisystem disorders caused by impaired mitochondrial function. The disease course for individuals with mitochondrial myopathies varies greatly from patient to patient because disease progression largely depends on the type of disease and on the degree of involvement of various organs which makes the prognosis unpredictable both within the same family and among families with the same mutation. This is particularly, but not exclusively, true for mitochondrial disorders caused by mtDNA point mutations, which are maternally inherited and subject to the randomness of the heteroplasmy. For this reason, the prognosis cannot be given by single mitochondrial disease, but should be formulated by any single mitochondrial disease-related event or complication keeping in mind that early recognition and treatment of symptoms are crucial for the prognosis. The following approach can help prevent severe organ dysfunctions or at least allow early diagnosis and treatment of disease-related complications.

Original languageEnglish
Pages (from-to)86-93
Number of pages8
JournalActa Myologica
Volume33
Issue number2
Publication statusPublished - Oct 1 2015

Fingerprint

Mitochondrial Diseases
Mitochondrial Myopathies
Mitochondrial DNA
Point Mutation
Disease Progression
Early Diagnosis
Mutation
Therapeutics

Keywords

  • Clinical heterogeneity
  • Dual genetic control
  • Intrafamilial variability
  • Multisystem disorders

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Moggio, M., Colombo, I., Peverelli, L., Villa, L., Xhani, R., Testolin, S., ... Sciacco, M. (2015). Mitochondrial disease heterogeneity: A prognostic challenge. Acta Myologica, 33(2), 86-93.

Mitochondrial disease heterogeneity : A prognostic challenge. / Moggio, Maurizio; Colombo, Irene; Peverelli, Lorenzo; Villa, Luisa; Xhani, Rubjona; Testolin, Silvia; Di Mauro, Salvatore; Sciacco, Monica.

In: Acta Myologica, Vol. 33, No. 2, 01.10.2015, p. 86-93.

Research output: Contribution to journalArticle

Moggio, M, Colombo, I, Peverelli, L, Villa, L, Xhani, R, Testolin, S, Di Mauro, S & Sciacco, M 2015, 'Mitochondrial disease heterogeneity: A prognostic challenge', Acta Myologica, vol. 33, no. 2, pp. 86-93.
Moggio M, Colombo I, Peverelli L, Villa L, Xhani R, Testolin S et al. Mitochondrial disease heterogeneity: A prognostic challenge. Acta Myologica. 2015 Oct 1;33(2):86-93.
Moggio, Maurizio ; Colombo, Irene ; Peverelli, Lorenzo ; Villa, Luisa ; Xhani, Rubjona ; Testolin, Silvia ; Di Mauro, Salvatore ; Sciacco, Monica. / Mitochondrial disease heterogeneity : A prognostic challenge. In: Acta Myologica. 2015 ; Vol. 33, No. 2. pp. 86-93.
@article{9fb6024e372f494b902386b7d278a230,
title = "Mitochondrial disease heterogeneity: A prognostic challenge",
abstract = "Mitochondrial diseases are a heterogeneous group of progressive, genetically transmitted, multisystem disorders caused by impaired mitochondrial function. The disease course for individuals with mitochondrial myopathies varies greatly from patient to patient because disease progression largely depends on the type of disease and on the degree of involvement of various organs which makes the prognosis unpredictable both within the same family and among families with the same mutation. This is particularly, but not exclusively, true for mitochondrial disorders caused by mtDNA point mutations, which are maternally inherited and subject to the randomness of the heteroplasmy. For this reason, the prognosis cannot be given by single mitochondrial disease, but should be formulated by any single mitochondrial disease-related event or complication keeping in mind that early recognition and treatment of symptoms are crucial for the prognosis. The following approach can help prevent severe organ dysfunctions or at least allow early diagnosis and treatment of disease-related complications.",
keywords = "Clinical heterogeneity, Dual genetic control, Intrafamilial variability, Multisystem disorders",
author = "Maurizio Moggio and Irene Colombo and Lorenzo Peverelli and Luisa Villa and Rubjona Xhani and Silvia Testolin and {Di Mauro}, Salvatore and Monica Sciacco",
year = "2015",
month = "10",
day = "1",
language = "English",
volume = "33",
pages = "86--93",
journal = "Acta Myologica",
issn = "1128-2460",
publisher = "Gaetano Conte Academy",
number = "2",

}

TY - JOUR

T1 - Mitochondrial disease heterogeneity

T2 - A prognostic challenge

AU - Moggio, Maurizio

AU - Colombo, Irene

AU - Peverelli, Lorenzo

AU - Villa, Luisa

AU - Xhani, Rubjona

AU - Testolin, Silvia

AU - Di Mauro, Salvatore

AU - Sciacco, Monica

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Mitochondrial diseases are a heterogeneous group of progressive, genetically transmitted, multisystem disorders caused by impaired mitochondrial function. The disease course for individuals with mitochondrial myopathies varies greatly from patient to patient because disease progression largely depends on the type of disease and on the degree of involvement of various organs which makes the prognosis unpredictable both within the same family and among families with the same mutation. This is particularly, but not exclusively, true for mitochondrial disorders caused by mtDNA point mutations, which are maternally inherited and subject to the randomness of the heteroplasmy. For this reason, the prognosis cannot be given by single mitochondrial disease, but should be formulated by any single mitochondrial disease-related event or complication keeping in mind that early recognition and treatment of symptoms are crucial for the prognosis. The following approach can help prevent severe organ dysfunctions or at least allow early diagnosis and treatment of disease-related complications.

AB - Mitochondrial diseases are a heterogeneous group of progressive, genetically transmitted, multisystem disorders caused by impaired mitochondrial function. The disease course for individuals with mitochondrial myopathies varies greatly from patient to patient because disease progression largely depends on the type of disease and on the degree of involvement of various organs which makes the prognosis unpredictable both within the same family and among families with the same mutation. This is particularly, but not exclusively, true for mitochondrial disorders caused by mtDNA point mutations, which are maternally inherited and subject to the randomness of the heteroplasmy. For this reason, the prognosis cannot be given by single mitochondrial disease, but should be formulated by any single mitochondrial disease-related event or complication keeping in mind that early recognition and treatment of symptoms are crucial for the prognosis. The following approach can help prevent severe organ dysfunctions or at least allow early diagnosis and treatment of disease-related complications.

KW - Clinical heterogeneity

KW - Dual genetic control

KW - Intrafamilial variability

KW - Multisystem disorders

UR - http://www.scopus.com/inward/record.url?scp=84946056836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946056836&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 86

EP - 93

JO - Acta Myologica

JF - Acta Myologica

SN - 1128-2460

IS - 2

ER -